EcoDrugPlus

Histone Deacetylase 5

Ensembl ID : ENSBGRG00000004281
Gene Symbol: HDAC5
1 Cross references
194 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSBGRG00000019900
Gene Symbol: HDAC6
1 Cross references
183 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSBGRG00000023703
Gene Symbol: HDAC7
1 Cross references
263 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSBGRG00000025035
Gene Symbol: HDAC8
1 Cross references
204 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSBGRG00000001751
Gene Symbol: HDAC9
1 Cross references
233 Possible Orthologues:

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSBGRG00000023799
Gene Symbol: HSD11B1
1 Cross references
267 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSBGRG00000010576
Gene Symbol: HCN4
1 Cross references
288 Possible Orthologues:

Hypocretin Receptor 1

Ensembl ID : ENSBGRG00000008440
Gene Symbol: HCRTR1
1 Cross references
95 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSBGRG00000024278
Gene Symbol: HCRTR2
1 Cross references
199 Possible Orthologues:

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSBGRG00000012224
Gene Symbol: IDO1
1 Cross references
98 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSBGRG00000008023
Gene Symbol: IKBKB
1 Cross references
197 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSBGRG00000022841
Gene Symbol: IMPDH1
1 Cross references
332 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).